Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.
about
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionA gender factor in shaping T-cell immunity to melanoma.Progressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restorationGender Disparity and Mutation Burden in Metastatic Melanoma.Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patients.
P2860
Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating Type-1 Anti-Tumor CD4
@nl
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@ast
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@en
type
label
Circulating Type-1 Anti-Tumor CD4
@nl
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@ast
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@en
prefLabel
Circulating Type-1 Anti-Tumor CD4
@nl
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@ast
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@en
P2093
P2860
P356
P1476
Circulating Type-1 Anti-Tumor ...... -Apoptotic in Cancer Patients.
@en
P2093
Amy K Wesa
James Harold Finke
Jennifer L Taylor
John M Kirkwood
Maja Mandic
Stergios Moschos
Walter J Storkus
William W Kwok
P2860
P356
10.3389/FONC.2014.00266
P577
2014-09-29T00:00:00Z